Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
In Vitro Effects of Sodium Benzoate on Th1/Th2 Deviation in Patients with Multiple Sclerosis.
[Improving the sexual quality of life of people with multiple sclerosis].
Teaching Video NeuroImages: Primary writing tremor: Lessons from a patient with multiple sclerosis.
Treatment of the osmotic demyelination syndrome: the earlier the better?
Resistance of subventricular neural stem cells to chronic hypoxemia despite structural disorganization of the germinal center and impairment of neuronal and oligodendrocyte survival.
The Pharmacological Effects and Mechanism of Tripterygium wilfordii Hook F in Central Nervous System Autoimmunity.
Myelin oligodendrocyte glycoprotein induces incomplete tolerance of CD4(+) T cells specific for both a myelin and a neuronal self-antigen in mice.
Endocannabionoid System in Neurological Disorders.
FDA Drug Safety Communication: FDA warns about cases of rare brain infection with MS drug Gilenya (fingolimod) in two patients with no prior exposure to immunosuppressant drugs
Altered Expression of Growth Associated Protein-43 and Rho Kinase in Human Patients with Parkinson's Disease.
Virtual reality in multiple sclerosis - A systematic review.
Effectiveness and safety of natalizumab in real-world clinical practice: Review of observational studies.
Myelin-targeted, texaphyrin-based multimodal imaging agent for magnetic resonance and optical imaging.
Sunlight exposure: Do health benefits outweigh harm?
Interleukins 17 and 10 in a sample of Egyptian relapsing remitting multiple sclerosis patients.
Sensory information treatment during disturbed standing posture in chronic acquired demyelinating polyneuropathies (CADP).
IL-3 promotes the development of experimental autoimmune encephalitis.
[The correlation factor analysis for conversion of clinically isolated syndrome to multiple sclerosis and neuromyelitis optica].
Safety and efficacy of dimethyl fumarate in multiple sclerosis: a multi-center observational study.
Construct validity of the walk ratio as a measure of gait control in people with multiple sclerosis without mobility aids.
VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
Social Cognition in Multiple Sclerosis: a Meta-Analysis.
Intravenously infused F3.Olig2 improve memory deficit via restoring demyelination in the aged hippocampus following experimental ischemic stroke.
[Therapy of fatigue in multiple sclerosis : A treatment algorithm].
Predictors of first-line treatment persistence in a Portuguese cohort of relapsing-remitting multiple sclerosis.
Pages
« first
‹ previous
…
782
783
784
785
786
787
788
789
790
…
next ›
last »